Stock market week-in-review for 5 large GI companies — Nov. 13-17

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 13 to Nov. 17.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $172.21 on Nov. 13
Peaked: $176.14 on Nov. 17
Closed: $174.92 on Nov. 17
Percent change between Nov. 13 and Nov. 17: 1.57 percent

2. Exact Sciences Corp.

Opened: $60.37 on Nov. 13
Peaked at open
Closed: $58.86 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -2.50 percent

3. Johnson & Johnson

Opened: $138.80 on Nov. 13
Peaked: $140.26 on Nov. 14
Closed: $137.98 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -0.59 percent

4. Synergy Pharmaceuticals

Opened: $2.72 on Nov. 13
Peaked at open
Closed: $1.95 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -28.30 percent

5. Valeant Pharmaceuticals

Opened: $15.41 on Nov. 13
Peaked at open
Closed: $14.69 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -4.67 percent

More articles on gastroenterology:
Physician fee schedule slashes GI anesthesia reimbursement — 5 insights
GI leader to know: Dr. John Vainder of Illinois Gastroenterology Group
Endoscopy a viable alternative to surgery for Barrett’s esophagus patients — 3 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.